CAS: 951395-08-7 - Tafamidis meglumine

Formel: C₁₄H₇Cl₂NO₃·C₇H₁₇NO₅

InChl: InChI=1S/C14H7Cl2NO3.C7H17NO5/c15-9-3-8(4-10(16)6-9)13-17-11-2-1-7(14(18)19)5-12(11)20-13;1-8-2-4(10)6(12)7(13)5(11)3-9/h1-6H,(H,18,19);4-13H,2-3H2,1H3/t;4-,5+,6+,7+/m.0/s1

InChI Key: InChIKey=DQJDBUPLRMRBAB-WZTVWXICSA-N

SMILES: O=C(O)C=1C=CC=2N=C(OC2C1)C=3C=C(Cl)C=C(Cl)C3.OCC(O)C(O)C(O)C(O)CNC

Synonyme:

• Vyndaqel
• Fx 1006A
• Tafamidis meglumine
• D-Glucitol, 1-deoxy-1-(methylamino)-, 2-(3,5-dichlorophenyl)-6-benzoxazolecarboxylate (1:1)

Tafamidis Meglumine

CAS: 951395-08-7

• Formel: C₁₄H₇Cl₂NO₃·C₇H₁₇NO₅
• Molekulargewicht: 308.11 195.22

tafamidis meglumine

CAS: 951395-08-7

Tafamidis meglumine (Fx-1006A) is a Potent and Selective Transthyretin Kinetic Stabilizer That Inhibits the Amyloid …

• Formel: C₂₁H₂₄Cl₂N₂O₈
• Reinheit: 99.01% - 99.98%
• Farbe und Form: Solid
• Molekulargewicht: 503.33

Tafamidis Meglumine

CAS: 951395-08-7

• Formel: C₁₄H₇Cl₂NO₃·C₇H₁₇NO₅
• Farbe und Form: Neat
• Molekulargewicht: 308.11 + 195.22

Tafamidis meglumine

CAS: 951395-08-7

Tafamidis meglumine is a drug that belongs to the class of drugs for treating cardiomyopathy. …

• Formel: C₂₁H₂₄Cl₂N₂O₈
• Reinheit: Min. 95%
• Molekulargewicht: 503.33 g/mol